- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Halozyme Therapeutics Inc+ Add to Watchlist
HALO:US15.3000 USD 0.2200 1.42%
As of 20:10:00 ET on 04/17/2015.
Company Profile for Halozyme Therapeutics Inc (HALO)
Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.
Halozyme Therapeutics Inc
Key Executives for Halozyme Therapeutics Inc (HALO)
|Helen I TorleyPresident/CEO||Athena CountouriotisChief Medical Officer|
|Harry J LeonhardtSenior VP/Chief Compliance Officer/General Counsel||David A RamsayVP/CFO|
|H Michael Shepard "Mike"VP/Chief Scientific Officer||James S Mazzola "Jim"VP:Investor Relations|